Home
>
National Drug Code (NDC)
>
Ezetimibe
Ezetimibe - 68462-226-90 - (Ezetimibe)
Drug Information of Ezetimibe
| Product NDC: | 68462-226 |
| Proprietary Name: | Ezetimibe |
| Non Proprietary Name: | Ezetimibe |
| Active Ingredient(s): | 10 mg/1 & nbsp; Ezetimibe |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ezetimibe
| Product NDC: | 68462-226 |
| Labeler Name: | Glenmark Generics Inc., USA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078560 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111231 |
Package Information of Ezetimibe
| Package NDC: | 68462-226-90 |
| Package Description: | 90 TABLET in 1 BOTTLE (68462-226-90) |
NDC Information of Ezetimibe
| NDC Code | 68462-226-90 |
| Proprietary Name | Ezetimibe |
| Package Description | 90 TABLET in 1 BOTTLE (68462-226-90) |
| Product NDC | 68462-226 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ezetimibe |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20111231 |
| Marketing Category Name | ANDA |
| Labeler Name | Glenmark Generics Inc., USA |
| Substance Name | EZETIMIBE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] |
